Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS: EMMA · Delayed Price · USD
0.110
+0.010 (10.00%)
May 6, 2024, 1:44 PM EDT - Market closed
Emmaus Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 6 | 13 | 82 | 60 | 83 | 8 | 11 | 4 | 6 | 22 | 23 | Upgrade
|
| Market Cap Growth | - | -84.35% | 36.76% | -27.76% | 906.99% | -22.98% | 178.74% | -36.96% | -72.67% | -1.72% | 1463.26% | Upgrade
|
| Enterprise Value | 40 | 36 | 110 | 77 | 101 | 6 | 5 | 4 | 8 | 23 | 21 | Upgrade
|
| PE Ratio | 25.02 | -1.20 | -5.16 | 44.42 | -1.52 | -0.86 | -1.51 | -0.65 | -1.81 | -8.39 | -2.08 | Upgrade
|
| PS Ratio | 0.21 | 0.70 | 3.99 | 2.60 | 3.66 | 6.28 | 83.54 | 45.25 | 61.03 | 165.42 | 173.72 | Upgrade
|
| PB Ratio | -0.18 | -0.38 | -3.83 | -11.10 | -7.53 | 2.06 | 2.36 | -15.01 | -1.26 | -12.69 | -10.53 | Upgrade
|
| P/FCF Ratio | -7.61 | -2.52 | -61.98 | -2.10 | -18.17 | -0.91 | -2.18 | -1.26 | -2.88 | -6.70 | -7.47 | Upgrade
|
| P/OCF Ratio | -7.78 | -2.54 | -65.59 | -24.54 | -18.41 | -0.91 | -2.24 | -1.29 | -2.89 | -6.83 | -7.49 | Upgrade
|
| EV/Sales Ratio | 1.40 | 1.95 | 5.33 | 3.31 | 4.44 | 4.26 | 41.41 | 42.61 | 84.36 | 167.21 | 164.09 | Upgrade
|
| EV/EBITDA Ratio | 685.02 | -5.46 | -13.67 | 4508.43 | -12.32 | -0.55 | -0.75 | -0.90 | -3.87 | -4.57 | 18.74 | Upgrade
|
| EV/EBIT Ratio | 2091.11 | -5.41 | -13.57 | -1782.40 | -12.21 | -0.55 | -0.75 | -0.90 | -3.86 | -4.57 | 18.95 | Upgrade
|
| EV/FCF Ratio | -46.01 | -7.05 | -82.81 | -2.68 | -22.03 | -0.62 | -1.08 | -1.18 | -3.98 | -6.77 | -7.05 | Upgrade
|
| Debt / Equity Ratio | -0.97 | -0.74 | -1.39 | -3.50 | -1.76 | 0.15 | 0.01 | -0.36 | -0.57 | -0.84 | -0.01 | Upgrade
|
| Debt / EBITDA Ratio | 609.24 | -3.81 | -3.72 | 1116.88 | -2.38 | -0.06 | -0.01 | -0.02 | -1.27 | -0.30 | 0.01 | Upgrade
|
| Debt / FCF Ratio | -40.11 | -4.92 | -22.54 | -0.66 | -4.25 | -0.06 | -0.01 | -0.03 | -1.31 | -0.44 | 0.00 | Upgrade
|
| Quick Ratio | 0.10 | -0.32 | 0.09 | 0.11 | 0.97 | 2.85 | 3.63 | 0.21 | 0.18 | 0.77 | 0.37 | Upgrade
|
| Current Ratio | 0.15 | 0.12 | 0.25 | 0.48 | 1.26 | 3.01 | 3.68 | 0.79 | 0.22 | 0.81 | 0.38 | Upgrade
|
| Asset Turnover | 0.58 | 0.38 | 0.36 | 0.39 | 0.38 | 0.26 | 0.02 | 0.06 | 0.18 | 0.10 | 0.09 | Upgrade
|
| Interest Coverage | 0.01 | -1.31 | -1.98 | -0.01 | -0.16 | -118.71 | -1076.30 | -1.38 | -10.32 | 3.28 | -3.26 | Upgrade
|
| Return on Equity (ROE) | 13.05% | 31.34% | 74.34% | -24.99% | 496.17% | -238.72% | -156.41% | 2316.14% | 69.87% | 151.16% | 504.97% | Upgrade
|
| Return on Assets (ROA) | -9.99% | -22.16% | -28.11% | 2.28% | -92.24% | -186.32% | -116.68% | -450.03% | -595.91% | -199.30% | -777.88% | Upgrade
|
| Return on Capital (ROIC) | -77.16% | 73.23% | -72.39% | -0.48% | -53.57% | -222.14% | -154.98% | 2312.34% | 128.43% | 1364.12% | 195.67% | Upgrade
|
| Earnings Yield | -80.37% | -83.03% | -19.39% | 2.25% | -65.88% | -116.10% | -66.26% | -154.27% | -55.32% | -11.91% | -47.97% | Upgrade
|
| FCF Yield | -14.93% | -39.62% | -1.61% | -47.60% | -5.51% | -110.00% | -45.85% | -79.48% | -34.70% | -14.92% | -13.39% | Upgrade
|
| Buyback Yield / Dilution | -179.22% | -0.38% | -0.73% | -15.71% | -4776.49% | -84.55% | -338.96% | -26.08% | -2.50% | -31.04% | -3860.25% | Upgrade
|
| Total Shareholder Return | -179.22% | -0.38% | -0.73% | -15.71% | -4776.49% | -84.55% | -338.96% | -26.08% | -2.50% | -31.04% | -3860.25% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.